Literature DB >> 22424538

Adverse drug reactions and safety considerations of NSAIDs: clinical analysis.

Shiv Bahadur1, Lav Keshri, Kamla Pathak.   

Abstract

NSAIDs are the most frequently used drugs for treatment, in Europe and the United States, accounting for approximately 5% of all prescriptions. Moreover, the use of NSAIDs is increasing because these constitute the first-line drug therapy for a wide range of rheumatic conditions. This increase is in part the result of the increasing population of elderly patients, who constitute the group of patients with greatest demand for these agents. There are many types of NSAIDs that vary in potency, action and potential side effects. Thus various efforts have been made to determine the safety considerations including adverse drug effects, duration of drug therapy, drug interactions, precautions and other drugs applied to reduce side effects. Researchers have introduced some novel techniques to diagnose NSAIDs related adverse effects on the gastrointestinal mucosa. The researchers dealing with the development of drug delivery system for these drugs should aim at designing a therapeutically efficacious dosage form with reduced side/adverse effects. Thus an effort has been made in this review to deal with the safety parameters of various NSAIDs with a special emphasis on preclinical and clinical safety analysis and various attempts to minimize the side effects by structural modification or by drug delivery system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22424538     DOI: 10.2174/157488611798918683

Source DB:  PubMed          Journal:  Curr Drug Saf        ISSN: 1574-8863


  4 in total

1.  Immunosuppressive agents are associated with peptic ulcer bleeding.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Naoki Ishige
Journal:  Exp Ther Med       Date:  2017-03-09       Impact factor: 2.447

2.  Efficacy of warming needle moxibustion in the treatment of ankylosing spondylitis: A protocol of a randomized controlled trial.

Authors:  Weizhong Ding; Shirong Chen; Xuexiang Shi; Yang Zhao
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

3.  Governor Vessel Moxibustion Therapy Improves Microbiota Structure in Ankylosing Spondylitis Patients.

Authors:  Guodong Sun; Qingbo Wang; Shengnan Cao; Haidong Xu; Yan Zhao
Journal:  Dis Markers       Date:  2021-12-20       Impact factor: 3.434

Review 4.  Safety of Non-Steroidal Anti-Inflammatory Drugs in the Elderly: An Analysis of Published Literature and Reports Sent to the Portuguese Pharmacovigilance System.

Authors:  Cristina Monteiro; Samuel Silvestre; Ana Paula Duarte; Gilberto Alves
Journal:  Int J Environ Res Public Health       Date:  2022-03-16       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.